The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bodick Neil since 2015.
The trader's CIK number is 1598099.
At the time of the last reporting, Bodick Neil was the Chief Medical Officer of Flexion Therapeutics Inc. (stock ticker symbol FLXN).
Also see all insider trading activities at Flexion Therapeutics Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | FLXN | 0 | $0 | 3,851 | $0 | 0 | $0 |
2019 | FLXN | 0 | $0 | 746 | $9,220 | 4,568 | $0 |
2018 | FLXN | 0 | $0 | 50,000 | $1,253,484 | 42,268 | $6,145 |
2017 | FLXN | 2,700 | $66,206 | 26,830 | $562,648 | 4,566 | $0 |
2016 | FLXN | 5,000 | $49,350 | 10,000 | $184,630 | 0 | $0 |
2015 | FLXN | 0 | $0 | 16,000 | $382,116 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-01-03 | FLXN | Sale | 3,851 | .00 | 0 |
2019-10-06 | FLXN | Option Ex | 4,568 | .00 | 0 |
2019-01-03 | FLXN | Sale | 746 | 12.36 | 9,220 |
2018-10-08 | FLXN | Option Ex | 4,566 | .00 | 0 |
2018-07-03 | FLXN | Sale | 16,492 | 25.00 | 412,300 |
2018-07-02 | FLXN | Sale | 33,508 | 25.10 | 841,184 |
2018-05-11 | FLXN | Option Ex | 37,702 | .16 | 6,145 |
2017-11-21 | FLXN | Buy | 2,700 | 24.52 | 66,206 |
2017-10-06 | FLXN | Option Ex | 4,566 | .00 | 0 |
2017-05-15 | FLXN | Sale | 6,830 | 19.10 | 130,453 |
2017-04-17 | FLXN | Sale | 5,000 | 28.53 | 142,650 |
2017-03-17 | FLXN | Sale | 5,000 | 20.41 | 102,040 |
2017-02-24 | FLXN | Sale | 5,000 | 19.15 | 95,760 |
2017-01-20 | FLXN | Sale | 5,000 | 18.35 | 91,745 |
2016-12-21 | FLXN | Sale | 10,000 | 18.46 | 184,630 |
2016-05-19 | FLXN | Buy | 850 | 10.00 | 8,500 |
2016-05-18 | FLXN | Buy | 2,100 | 10.20 | 21,420 |
2016-05-17 | FLXN | Buy | 800 | 9.60 | 7,680 |
2016-05-16 | FLXN | Buy | 1,250 | 9.40 | 11,750 |
2015-03-16 | FLXN | Sale | 4,000 | 25.38 | 101,500 |
2015-03-10 | FLXN | Sale | 4,000 | 24.26 | 97,056 |
2015-03-04 | FLXN | Sale | 4,000 | 23.45 | 93,792 |
2015-02-26 | FLXN | Sale | 4,000 | 22.44 | 89,768 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bodick Neil (Chief Medical Officer of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.